Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ITI-214
print preview
bookmark
share with colleague
General Information
Company
Intra-Cellular Therapies Inc.
Description
Phosphodiesterase-1 (PDE-1) inhibitor
Molecular Target
Phosphodiesterase-1 (PDE-1)
Mechanism of Action
Phosphodiesterase-1 (PDE-1) inhibitor
Latest Stage of Development
Phase I
Indication
Schizophrenia
Partner
Takeda Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy